KIDNEY TRANSPLANT

This study looks at how well the HPV9 vaccine (Gardasil 9) works in people who have had a kidney or other solid organ transplant. Researchers will measure antibody levels in 30 participants over 24 months and compare them to healthy individuals. The goal is to see if the vaccine …

This study tests whether a supervised fitness program can help people with obesity lose weight so they can become eligible for a kidney transplant. Ten adults who are currently inactive on the transplant waitlist due to a high body mass index will take part. The main goal is to s…

This early-phase study tests whether a single infusion of special immune cells (regulatory dendritic cells) from the donor, given one week before a kidney transplant, is safe and feasible. It involves 14 kidney recipients and their living donors, with recipients followed for two …

This study looks at whether giving testosterone to men with low testosterone and kidney failure before a kidney transplant can help them recover better and more safely. About 50 men will receive testosterone for at least 3 months before their transplant, and their outcomes will b…

This study tests whether dapagliflozin, a drug used for diabetes, can help protect kidney function in people who received a kidney transplant from a living donor. About 54 adults will take the drug daily or receive standard care. Researchers will measure kidney function, scarring…

This study examines how donated kidneys are used across different countries to find ways to reduce waste and improve transplant access. Researchers will analyze data from 300,000 kidney donations over 15 years. The goal is to identify best practices that could help more patients …

This study checks kidney transplant patients for inherited gene changes that raise cancer risk. Researchers want to see if knowing these risks leads to better cancer screening. The goal is to improve long-term health for transplant recipients.